Humacyte HUMA Earnings Call Transcripts

NASDAQ HUMA
$0.59 +0.00 (+0.29%)
At close: Nov 11, 2026 · 4:00 PM EST
5 earnings calls on file for Humacyte, from Q3 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Humacyte Q3 2026 Earnings Call

Nov 10, 2026 5,952 words · 26 min read
  • Dr. Laura NiklasonPresident and Chief Executive Officer
  • Jim MercadanteChief Commercial Officer
  • Dale SanderChief Financial Officer and Chief Corporate Development Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Humacyte Earnings Call Transcripts

Calls5
LatestNov 10, 2026
SinceQ3 2025

Fiscal 2026

Fiscal 2025

All 5 Humacyte transcripts Register to get access to Humacyte’s earnings call transcripts.